Nueva Immulina® puede potenciar la resistencia al virus H1N1

Ahora que la OMS ha declarado oficialmente una pandemia global de influenza, la necesidad de protegernos a nosotros mismos y a nuestras familias de la infección se ha convertido en algo crítico. En el Reino Unido ya se han diagnosticado mucho más de 7000 casos de la nueva cepa del virus de la inflluenza A de origen porcino del subtipo H1N1y ya
están alcanzando todas las areas del país. Particularmente las escuelas han sentido el impacto como es el caso del colegio Eton cuyos alumnos han debido ser cuarentenados de todo contacto exterior hasta que los casos infectados se hayan recuperado totalmente.
Otros ejemplos confirman la propagación creciente del virus.
Un nuevo producto lanzado en el Reino Unido, la Immulina®, la cual potencia las defensas naturales del organismo,se ha revelado como “el producto natural más inmunoestimulador descubierto hasta el presente”

http://www.medicalnewstoday.com/articles/163253.php

Immulina® is a brand new, unique, scientifically tested and scientifically proven natural food supplement which the whole population may benefit by taking every day to support the body’s immune system by maintaining the function of the immune system cells. It is a
patented and proprietary extract based on a bioactive micro algae complex from Arthrospira Platensis and its unique formulation means it is 20-25 times more bioactive than many other products². It also differs from antibiotics or anti-viral drugs by acting as a resistance booster.

A New Scientific Study shows Immulina® has a substantial effect on ameliorating symptoms caused by the virus H1N1. The recently concluded animal study reported by Scandinavian Clinical Nutrition (SCN) in May 2009, was conducted at the Louisiana State University School of Veterinary Medicine, Division of Biotechnology & Molecular Medicine (BIOMED). “The results are promising with regard to preventative effects and milder symptoms of H1N1 infection. Immulina® tested in mice, showed a significant reduction of both symptoms and lung tissue damage after being infected by the influenza virus H1N1,
compared to placebo,” says Dr. Lars Lindmark, CEO of Kasima Medical Development AB, ho has been involved with the research of Immulina® during the last five years.
It should be noted that this trial did not test against the new swine-origin strain of H1N1 influenza A specifically, but demonstrated the potential for Immulina® to help manage the impact of H1N1 in general.

The study leader, Professor Gus Kousoulas summarised the outcome of the research:

“The experimental results collectively indicate a substantial effect of the nutritional supplement on ameliorating clinical symptoms and adverse pathological implication of influenza infection in the mouse model and lead us to believe that this micro algae compound may be able to boost resistance to H1N1 influenza”.
Further studies on the immune-enhancing effects of Immulina® on humans and animals have been conducted at several renowned immunology specialist organisations, such as the Karolinska Institutet in Stockholm and at Rigshospitalet in Copenhagen, resulting in several published articles in peer-reviewed scientific journals.

Arriving in the UK from this week, Immulina® offers genuine support in enabling families to boost the body’s natural immune system. Available from Nutri Centre www.nutricentre.com /

call 08456026744, pharmacies and health food stores, Immulina® costs £24.95 for around one month’s supply of 30 capsules, to be taken once daily.

Notes

Immulina® – Product Profile
Patented bioactive Arthrospira platensis complex
– Supports the body’s natural resistance
– Maintains the function of immune system cells
Dosage: 1 capsule a day. If feeling stressed or tired, you may take 2 capsules a day. Daily dosage should not be exceeded.

1 capsule contains:
200mg patented Arthrospira platensis extract (59%), corresponding to 1.5g dried algae arthrospira platensis.
Pregnant women and children under 12 months should consult with a health care professional before taking the product.
Made in the UK.

Source
WHO